Global Heart Valves Market Professional Survey Report 2019

Heart valve disease occurs when heart valves do not work properly the way they should. The heart has four valves (the tricuspid, pulmonary, mitral, and aortic valves); these valves have tissue flaps that open and close at each heartbeat. The heart valve flaps make sure blood flows in the right direction through your heart's and to the rest of your body. Birth defects, age-related changes, infections, or other medical conditions can cause one or more of your heart valves to not open fully or to let blood leak back into the heart chambers. These conditions make your heart work harder and affect its ability to pump blood.
The normal invasive and MI procedures used by physicians often lead to complications like pleural effusion, arrhythmia, pleuritis, pericardial effusion, pericarditis, and infections in the lungs. This has led to physicians opting for minimally invasive catheter-based heart valve replacement surgery to reduce complications. Proven to be safe and efficient, these minimally invasive procedures reduce the need for blood transfusions, the risk of infections, hospital stays, and lead to rapid healing and recovery and better clinical outcome. As a result of their benefits, many cardiologists are opting these methods over invasive, and open heart surgeries and vendors have started manufacturing products for use during minimally invasive procedures. This increase in implementation of minimally invasive procedures is considered to be one of the primary drivers that will fuel the growth of this market in the coming years.
The demand for heart valves in the US has been rising rapidly since 2013, which will likely continue during the forecast period. The incidence of heart valve diseases in the country is rising, particularly among people aged above 70. Heart valve replacement procedures are minimally invasive and are considered safe and efficient. Many people prefer these procedures to open-heart surgeries. Favorable reimbursement coverage by Medicare governs these procedures leading many vendors to focus on launching their products in the US. These vendors are conducting clinical trials to prove their products' safety and efficacy profiles and gain FDA approvals. Approval of these devices will help in increasing the overall market revenue of heart valves in the country and boost market's growth globally.

The global Heart Valves market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Heart Valves volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heart Valves market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Heart Valves in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Heart Valves manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abbott Laboratories
Boston Scientific Corporation
Cryolife
Edwards Lifesciences
On-X Life Technologies
LivaNova
Medtronic
Micro Interventional Devices
Neovasc
Sorin Group
St. Jude Medical
TTK Healthcare

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Transcatheter Heart Valves
Tissue Heart Valves
Mechanical Heart Valves

Segment by Application
Hospitals
Ambulatory Surgical Centers